Earnings Feed
Start Free
Home/Filings/4/0001235802-24-000018
4//SEC Filing

Landry John 4

Accession 0001235802-24-000018

CIK 0001253176other
View on SEC.govCompany Profile

Filed

Feb 28, 7:00 PM ET

Accepted

Feb 29, 5:13 PM ET

Size

38.0 KB

Accession

0001235802-24-000018

Insider Transaction Report

Form 4
Period: 2024-02-27
VAPOTHERM INCVAPO
Landry John
See Remarks
Transactions
  • Award

    Stock Option (right to buy)

    2024-02-27+2,150→ 2,150 total
    Exercise: $0.92Exp: 2031-01-01→ Common Stock (2,150 underlying)
  • Award

    Stock Option (right to buy)

    2024-02-27+3,250→ 3,250 total
    Exercise: $0.92Exp: 2030-01-01→ Common Stock (3,250 underlying)
  • Award

    Stock Option (right to buy)

    2024-02-27+3,503→ 3,503 total
    Exercise: $0.92Exp: 2029-01-11→ Common Stock (3,503 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2024-02-27−9,943→ 0 total
    Exercise: $97.28Exp: 2030-01-01→ Common Stock (9,943 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2024-02-27−2,150→ 0 total
    Exercise: $214.88Exp: 2031-01-01→ Common Stock (2,150 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2024-02-27−3,503→ 0 total
    Exercise: $137.20Exp: 2029-01-11→ Common Stock (3,503 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2024-02-27−3,250→ 0 total
    Exercise: $97.28Exp: 2030-01-01→ Common Stock (3,250 underlying)
  • Award

    Stock Option (right to buy)

    2024-02-27+9,943→ 9,943 total
    Exercise: $0.92Exp: 2030-01-01→ Common Stock (9,943 underlying)
  • Award

    Stock Option (right to buy)

    2024-02-27+6,625→ 6,625 total
    Exercise: $0.92Exp: 2032-05-10→ Common Stock (6,625 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2024-02-27−3,062→ 0 total
    Exercise: $165.68Exp: 2032-01-01→ Common Stock (3,062 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2024-02-27−6,625→ 0 total
    Exercise: $25.28Exp: 2032-05-10→ Common Stock (6,625 underlying)
  • Award

    Stock Option (right to buy)

    2024-02-27+6,834→ 6,834 total
    Exercise: $0.92Exp: 2033-01-02→ Common Stock (6,834 underlying)
  • Award

    Stock Option (right to buy)

    2024-02-27+3,062→ 3,062 total
    Exercise: $0.92Exp: 2032-01-01→ Common Stock (3,062 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2024-02-27−6,834→ 0 total
    Exercise: $21.60Exp: 2033-01-02→ Common Stock (6,834 underlying)
Holdings

  • Common Stock

    (indirect: By IRA)
    425

  • Common Stock

    68,918

  • Common Stock

    (indirect: By IRA)
    1,693
Footnotes (8)
  • [F1]Includes 625 shares that were purchased under the Vapotherm, Inc. 2018 Employee Stock Purchase Plan, 23,845 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Vapotherm, Inc. Amended and Restated 2018 Equity Incentive Plan and 10,760 shares held by the reporting person's Roth IRA.
  • [F2]The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
  • [F3]This option, which was previously subject to four-year vesting, is fully vested.
  • [F4]The transactions reported herein reflect a stock option repricing effective February 27, 2024 pursuant to which the exercise price of the repriced options was amended to reduce the exercise price to $0.915 per share, the closing price of the Issuer's common stock on February 27, 2024. There is no change to the expiration dates or the vesting schedule of the repriced options.
  • [F5]This option vested as to 25% of the underlying shares on January 1, 2022, and thereafter, as to the remaining 75% of underlying shares, in 36 monthly installments, provided that the Reporting Person continues to serve as an employee or other service provider to the Issuer on each vesting date and otherwise subject to the Issuer's applicable equity incentive plan.
  • [F6]This option vested as to 25% of the underlying shares on January 1, 2023, and thereafter, as to the remaining 75% of underlying shares, in 36 monthly installments, provided that the Reporting Person continues to serve as an employee or other service provider to the Issuer on each vesting date and otherwise subject to the Issuer's applicable equity incentive plan.
  • [F7]This option vested as to 25% of the underlying shares on January 1, 2024, and thereafter, as to the remaining 75% of underlying shares, in 36 monthly installments, provided that the Reporting Person continues to serve as an employee or other service provider to the Issuer on each vesting date and otherwise subject to the Issuer's applicable equity incentive plan.
  • [F8]This option vested as to 25% of the underlying shares on January 2, 2024, and thereafter, as to the remaining 75% of underlying shares, in 36 monthly installments, provided that the Reporting Person continues to serve as an employee or other service provider to the Issuer on each vesting date and otherwise subject to the Issuer's applicable equity incentive plan.

Documents

1 file

Issuer

VAPOTHERM INC

CIK 0001253176

→
Entity typeother

Related Parties

1
  • filerCIK 0001753455

Filing Metadata

Form type
4
Filed
Feb 28, 7:00 PM ET
Accepted
Feb 29, 5:13 PM ET
Size
38.0 KB
View on SEC.gov